CD20 x CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting

Liu, XY; Zhao, JJ; Guo, XQ; Song, YP

Song, YP (通讯作者)，Zhengzhou Univ, Affiliated Hosp 1, Dept Hematol, Zhengzhou 450052, Henan, Peoples R China.

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023; 16 (1):

Abstract

Multiple bispecific antibodies (bsAbs) have been approved for cancer immunotherapy. Several CD20 x CD3 bsAbs have demonstrated significant anti-B-cell......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索